皮肤T细胞淋巴瘤的免疫治疗

Immunotherapy for cutaneous T-cell lymphoma

阐述免疫治疗包括细胞因子〔白介素 2 (IL 2 )、白介素 1 2 (IL 1 2 )〕、免疫核素 (1 31 I T1 0 1 )、免疫毒素[IL 2 融合毒素 (DAB 389 IL2 ) ]、单克隆抗体抗CD5(T1 0 1 )和某些新的局部免疫调节剂 (如CTLA4 1 g、LFA tip、BCX 34)、维甲酸类药物如targretin、panretin与光效应药物如hypercin或δ

WTBZ]To describe the immunotherapy including cytokines [interleukin 2(IL 2), Interleukin 12(IL 12)], immunonuclide ( 131 I T101), immunotoxin [IL 2 fusion toxin (DAB389 IL 2)], monoclonal antibody antiCD5(T101), some new topical immunomodullary compounds such as ATLA4 1g, LFA tip, BCX 34, retinodes such as targretin, panretin and photodynamic compounds such as hypercin or δ ALA for trial treatments of cutaneous T cell lymphoma.